MONLAB
MONLAB SL is a privately held Spanish distributor of clinical diagnostic laboratory materials, supplying rapid tests, RT-PCR platforms, automated readers, and consumables to clinical laboratories across Spain through direct enterprise sales and exclusive distribution partnerships.
- Company typePrivate
- Founded1985
- HeadquartersBarcelona, Spain
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What MONLAB does
MONLAB SL is a privately held Spanish distributor and supplier of clinical diagnostic laboratory materials, founded in 1985 and headquartered in Cornellà de Llobregat, Barcelona. The company sells a comprehensive portfolio of in vitro diagnostic (IVD) products — including immunochromatographic rapid tests (SARS-CoV-2, Influenza A+B, RSV, Adenovirus, Strep A, Procalcitonin, Syphilis, Mononucleosis), an RT-PCR molecular biology platform (AIGS), biochemistry reagents, immunology products (AFIAS), hematology equipment, microbiology tests, urine and breath tests, preanalytical disposables, and infusion devices — directly to clinical laboratories through a field sales model with quote-based pricing. Its proprietary iPeak+® Reader, featuring Flash Eye® technology, provides automated quantitative and qualitative rapid test reading with HL7-based Laboratory Information System (LIS) integration, Datamatrix sample traceability, and connectivity via Wi-Fi, Ethernet, and LAN.
The company's revenue model is one-time product sales of consumables and instruments to clinical laboratory customers in Spain, with no subscription, licensing, or recurring service revenue disclosed. MONLAB holds exclusive Spain distribution rights for advanced diagnostic solutions from foreign manufacturers, positioning it as the channel partner of choice for IVD vendors entering the Spanish market. The company serves a single customer vertical (clinical laboratories), with end-use cases spanning infectious disease screening, respiratory pathogen detection, gastrointestinal diagnostics, sepsis markers, and general laboratory workflow. Marketing is conducted through a healthcare-professional-only website with downloadable PDF catalogs, attendance at industry conferences (notably SEIMC), and direct phone/email outreach. The customer base is fragmented across many individual laboratories rather than concentrated in a few anchor accounts.
Operational posture is that of an established, mature SME: the company employs 11-50 people, relocated to new facilities in October 2022 with a showroom and modern offices, celebrated its 40th anniversary in May 2025, and launched the DEBUNK Plus+ AFR-700 fluorescence immunoassay analyzer in September 2025 as its most recent product expansion. There is no disclosed external investment, parent company, M&A activity, or geographic expansion beyond Spain.
MONLAB firmographics
Firmographics- Name
- MONLAB
- Legal name
- MONLAB SL
- Website
- https://monlab.es
- Company type
- Private
- Founded year
- 1985
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- MONLAB SL is a privately held Spanish distributor of clinical diagnostic laboratory materials, supplying rapid tests, RT-PCR platforms, automated readers, and consumables to clinical laboratories across Spain through direct enterprise sales and exclusive distribution partnerships.
- Ownership category
- akta.pro rank
MONLAB industry classification
Industry- Product category
- In Vitro Diagnostics (Clinical Laboratory Reagents and Instruments)
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)
- akta.pro secondary industries
- Clinical Chemistry & Immunoassay Systems (HLAHAAAA), Microbiology & Infectious Disease Diagnostics (Culture/ID/AST) (HLAHAAAC), Hematology & Coagulation Diagnostics (HLAHAAAB)
Keywords
Where MONLAB is headquartered
LocationHeadquarters
- HQ city
- Barcelona
- HQ country
- Spain
- HQ region
- Europe
Offices2 records
Markets served
MONLAB business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Diagnostic Products Sales: MONLAB generates revenue through the sale of clinical diagnostic laboratory materials including rapid tests, biochemistry reagents, immunology products, microbiology tests, hematology equipment, and related consumables. Products are sold directly to clinical laboratories.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
MONLAB product offering
Product offeringCore offering
MONLAB supplies in vitro diagnostic (IVD) products — including immunochromatographic rapid tests, biochemistry reagents, immunology products, microbiology tests, hematology equipment, point-of-care devices, and RT-PCR molecular biology platforms — to clinical diagnostic laboratories across Spain. Its proprietary iPeak+® automated rapid test reader (with Flash Eye® technology) and recently launched DEBUNK Plus+ AFR-700 fluorescence immunoassay analyzer anchor a portfolio covering infectious disease screening (COVID-19, Influenza, RSV, Adenovirus, Strep A), respiratory pathogens, gastrointestinal diagnostics, urinary analysis, hematology, and hospital consumables.
Product overview
Monlab is a clinical diagnostic laboratory material supplier based in Spain, offering a comprehensive portfolio of rapid tests, point-of-care devices, and molecular biology solutions. The core offering includes the iPeak+® Reader for automated rapid test reading, alongside numerous rapid test cassettes covering respiratory infections (SARS-CoV-2, Influenza, RSV, Adenovirus, Strep A), blood/serum tests (COVID-19 IgG/IgM, Procalcitonin, Syphilis, Mononucleosis), fecal tests, and urine tests. The AIGS Platform for RT-PCR extends the portfolio into molecular diagnostics. Products integrate with Laboratory Information Systems (LIS) via HL7 and support Datamatrix-based sample traceability.
Differentiator
Problem solved
Functional benefit
Products and services
- iPeak+® Reader Automated portable rapid test reader equipped with Flash Eye® proprietary technology for qualitative or quantitative assays. Reads cassettes and test strips for various sample types (respiratory, fecal, urine, blood/serum). Features 16GB internal memory, 200-result storage with images, support for up to 7 test lines per strip, 15-second measurement time, HL7 connectivity for LIS integration, Wi-Fi/Ethernet/LAN, Datamatrix sample traceability, and 4-hour battery autonomy. Targeted at clinical diagnostic laboratories.
- AIGS Platform for RT-PCR RT-PCR molecular biology platform for COVID-19 and other pathogen detection within Monlab's COVID diagnostic solutions portfolio, used by clinical laboratories for molecular diagnostic testing.
- DEBUNK Plus+ AFR-700 Fluorescence immunoassay analyzer with internal incubation that helps optimize and simplify rapid tests in laboratories. Features fluorescence detection technology for enhanced sensitivity in clinical laboratory rapid testing workflows.
- SARS CoV-2 Ag Immunochromatographic test for qualitative detection of SARS-CoV-2 antigens from nasopharyngeal swab samples or samples in transport media, used as an aid in the diagnosis of COVID-19 in clinical laboratories.
- Strep A MonlabTest Immunochromatographic test for qualitative detection of Group A Streptococcus antigens from throat swab samples as an aid in the diagnosis of GAS infection with sore throat.
- Influenza A+B MonlabTest Immunochromatographic test for qualitative detection of Influenza type A (including subtypes A/H1N1, A/H3N2, A/H5N1) and type B antigens in human nasopharyngeal samples for diagnosis of Influenza infection.
- RSV MonlabTest Immunochromatographic test for qualitative detection of RSV antigens in human nasopharyngeal samples for diagnosis of RSV infection.
- RSV-Adenovirus combo MonlabTest Immunochromatographic test for qualitative detection of RSV and Adenovirus antigens in human nasopharyngeal samples for diagnosis of respiratory infections.
- Covid-19 IgG/IgM Test cassette for qualitative detection of IgG and IgM antibodies against SARS-CoV-2 in serum or plasma for aid in the diagnosis of COVID-19.
- Procalcitonina (StrongStep) Rapid immunochromatographic semi-quantitative test for detection of procalcitonin in human serum or plasma, used for diagnosis and monitoring of severe bacterial infections and sepsis.
- Sífilis Ultra Test One-step rapid chromatographic immunoassay for qualitative detection of Treponema Pallidum IgG and IgM antibodies in serum or plasma as an aid in the diagnosis of Syphilis.
- Mononucleosis Rapid Test Rapid chromatographic immunoassay for quantitative detection of infectious mononucleosis heterophilic antibodies in whole blood, serum, or plasma as an aid in the diagnosis of infectious mononucleosis.
Companies that use MONLAB
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
MONLAB technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
Feature3 records
MONLAB partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Advanced Diagnostic Solution ProviderscoreMONLAB is the exclusive distributor in Spain for advanced diagnostic solutions presented at industry events. This exclusive distribution arrangement represents a core business relationship for bringing innovative diagnostic products to the Spanish market.
Scale indicators2 records
Recent moves6 records
Expansion highlights4 records
MONLAB competitors and assessment
Company assessmentBroad incumbents
- Grifols: Spanish-headquartered global diagnostics and blood-products major with a Diagnostic Solutions division that sells immunoassay and clinical chemistry analyzers into the same Spanish hospital and reference-lab customers as MONLAB. Larger, vertically integrated competitor.
- BioMérieux: French global leader in in vitro diagnostics for clinical and industrial applications. Overlaps with MONLAB's microbiology, immunoassay, and clinical chemistry lines but operates at much greater scale with full R&D, manufacturing, and global distribution.
- Hologic: US-headquartered global diagnostics and women's health major with strong molecular (Panther) and rapid-test franchises. Overlaps with MONLAB's RT-PCR (AIGS) and infectious-disease rapid test lines but operates at much greater scale and with direct Spanish sales presence.
Direct peers
- Certest Biotec: Spanish manufacturer of IVD rapid tests and molecular diagnostics based in Zaragoza. Direct competitor to MONLAB in the Spanish clinical-laboratory channel, with overlapping product categories (respiratory, infectious disease, drugs of abuse) and similar size profile.
- EKF Diagnostics Holdings: UK-listed point-of-care and central-lab IVD company of comparable size to MONLAB, selling hemoglobin, glucose, and infectious disease rapid tests through specialty distribution channels in Europe. Comparable business model as a focused mid-market IVD player.
- BIOSYNEX: French IVD company specializing in rapid diagnostic tests (infectious disease, drugs of abuse, pregnancy) and readers, with European distribution. Comparable product mix to MONLAB, particularly on rapid immunochromatographic tests and POC readers.
Regional players
- Palex Medical: Spanish hospital and laboratory solutions distributor representing multiple international IVD and medical-device brands. Competes with MONLAB for the same Spanish clinical-lab procurement budgets and as an alternative exclusive-distribution partner for international vendors.
- RAL Técnica para el Laboratorio: Spanish distributor of clinical laboratory products (reagents, consumables, equipment). Closest direct competitor to MONLAB on the Spanish distribution side, with overlapping target customers and similar GTM motion.
Emerging players
- SD Biosensor: Korean IVD manufacturer of rapid immunochromatographic tests (COVID, influenza, RSV) and POC molecular platforms. Comparable rapid-test portfolio and increasingly active in European markets where MONLAB competes.
- Hangzhou AllTest Biotech: Chinese manufacturer of lateral flow and rapid diagnostic tests distributed globally, including in Europe. Comparable product category (immunochromatographic cassettes) but competes primarily on price from a low-cost manufacturing base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
MONLAB social profiles
Digital presenceMONLAB financial estimates
Financial estimateRevenue estimate
Valuation estimate
MONLAB leadership team
Management profileNumber of profiles
MONLAB funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MONLAB M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MONLAB
What does MONLAB do?
MONLAB supplies in vitro diagnostic (IVD) products — including immunochromatographic rapid tests, biochemistry reagents, immunology products, microbiology tests, hematology equipment, point-of-care devices, and RT-PCR molecular biology platforms — to clinical diagnostic laboratories across Spain. Its proprietary iPeak+® automated rapid test reader (with Flash Eye® technology) and recently launched DEBUNK Plus+ AFR-700 fluorescence immunoassay analyzer anchor a portfolio covering infectious disease screening (COVID-19, Influenza, RSV, Adenovirus, Strep A), respiratory pathogens, gastrointestinal diagnostics, urinary analysis, hematology, and hospital consumables.
Is MONLAB a public or private company?
MONLAB is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was MONLAB founded?
MONLAB was founded in 1985. It employs 11 to 50 people.
Where is MONLAB based?
MONLAB is headquartered in Barcelona, Spain, in the Europe region.
How does MONLAB make money?
One revenue line is on record: diagnostic Products Sales.
Who are MONLAB's main competitors?
Broad incumbents on record are Grifols, BioMérieux and Hologic. Direct peers are Certest Biotec, EKF Diagnostics Holdings and BIOSYNEX. Regional players are Palex Medical and RAL Técnica para el Laboratorio. Emerging players are SD Biosensor and Hangzhou AllTest Biotech.
Does MONLAB have an API?
No public API is recorded for MONLAB.
What industry is MONLAB in?
MONLAB's product category is In Vitro Diagnostics (Clinical Laboratory Reagents and Instruments). Its primary akta.pro industry code is HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument), with a secondary code of HLAHAAAA, Clinical Chemistry & Immunoassay Systems. Its NAICS code is 325413 and its SIC code is 2835.